Subscribe To
HCW Biologics Enters CRADA with National Cancer Institute
NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer MIRAMAR, Fla., Dec. 08, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between inflammation […] The post HCW Biologics Enters CRADA with National Cancer Institute appeared first on ForexTV...
Read More
Posted: Dec 8 2022, 12:55
Author Name: forextv
Views: 110712